Blood Advances Journal Issues 2 Research Articles in Aug. 27, 2019 Edition
WASHINGTON, Aug. 17 -- Blood Advances, a medical journal that says it covers all aspects of hematology, including disorders of leukocytes, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology and hematologic oncology from the American Society of Hematology, published two research articles on the following topics in its Aug. 27, 2019 edition:
* Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
* Monocyte proco . . .
* Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
* Monocyte proco . . .